455 results
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO publishes vaccine position papers providing global vaccine and immunization recommendations for...
Presentation for NITAGs and Programme managers on the evidence for single dose HPV vaccine schedules
Comparison table of WHO prequalified typhoid conjugate vaccines (TCVs).
These country-specific resources outline the burden of typhoid (provided by the Global Burden of Disease study) and the potential benefits of new typhoid conjugate vaccines in each country. They are...
Monkeypox, now also known as mpox, is a zoonotic disease1 caused by a virus: species Monkeypox virus, genus Orthopox- virus (MPXV). The wild mammalian reservoir species is unknown. There are 2...
Monkeypox, now also known as mpox, is a zoonotic disease1 caused by a virus: species Monkeypox virus, genus Orthopox- virus (MPXV). The wild mammalian reservoir species is unknown. There are 2...
Ces recommandations sur l’utilisation des vaccins anti-PVH ont été émises par le Groupe stratégique consultatif d’experts sur la vaccination (SAGE) de l’OMS lors de sa réunion d’avril...
This background document has been prepared by the SAGE working group on smallpox and monkeypox vaccines to inform the discussions of SAGE at its 3-7 October 2022 meeting.
Annexes to the Vaccines and immunization for monkeypox interim guidance
Estas recomendaciones provisionales1 se refieren a la vacuna mRNA-1273, fabricada por Moderna, que también se conoce como vacuna anti-COVID-19 de Moderna. En algunos países la vacuna se...
This Good Practice Statement summarizes current evidence on these variant-containing mRNA vaccines and provides guidance on their use in the context of the continued availability of ancestral...
Le présent document remplace la précédente note de synthèse sur les vaccins anti-hépatite A, publiée par l’OMS en 2012. Il contient des recommandations sur l’utilisation hors indications de...
This document replaces the 2012 WHO position paper on hepatitis A vaccines. It contains off-label recommendations.
Recomendaciones provisionales para el uso de la vacuna de Valneva (VLA2001) contra la COVID-19: orientaciones provisionales, versión inicial: 18 de agosto de 2022,Recomendaciones provisionales...
Recommandations provisoires concernant l’utilisation du vaccin de Valneva (VLA2001) contre la COVID-19 : orientations provisoires, première publication : 18 août 2022
Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista OMS de uso en emergencias: orientaciones provisionales, primera...
The vaccine tracker was developed by World Bank in an effort to identify countries in urgent need of financial and operational support for vaccine deployment readiness, and to monitor, track and...
This is a link to a set of posts on vaccine introduction, supply chain and storage planning, and communication with communities,This is a link to a set of posts on vaccine introduction, supply chain...
This is a link to a post on how to generate demand for Covid-19 vaccination,This is a link to a post on how to generate demand for Covid-19 vaccination
This is Rockefeller microsite on Covid-19 vaccine particularly focusing on increasing demand and accelerating global equity,This is Rockefeller microsite on Covid-19 vaccine particularly focusing on...
Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Analyse de la réponse du...
Analyse de la situation de vaccination contre la COVID-19 en RDC et stratégies de couverture des personnes les plus vulnérables,Analyse de la situation de vaccination contre la COVID-19 en RDC et...
Revue sur l'expérience du Rwanda en matière de mise à l’échelle de méthodes de suivi en temps réel et d’utilisation de solutions numériques pour renforcer la surveillance de la COVID-19,...
Highlighting Rwanda’s Experience Scaling Real-time Monitoring Approaches Using Digital Solutions to Support COVID-19 Surveillance, COVID-19 Vaccination and Case Management,Highlighting Rwanda’s...
Leasons learned on vaccination against COVID-19,Leasons learned on vaccination against COVID-19,Leasons learned on vaccination against COVID-19
India: Description de la plateforme électronique de vaccination contre la COVID-19 pour l’enregistrement et la déclaration
,India: Description de la plateforme électronique de vaccination...
The Gambia: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,The Gambia: Analysis of country COVID-19 response, identifying best...
RDC: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,RDC: Analyse de la...
Guinée Bissau: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention pratiques...
Somalia: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Somalia: Analysis of country COVID-19 response, identifying best...
Uganda: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Uganda: Analysis of country COVID-19 response, identifying best...
Guinea Bissau: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Guinea Bissau: Analysis of country COVID-19 response,...
South Sudan: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,South Sudan: Analysis of country COVID-19 response, identifying...
DRC: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,DRC: Analysis of country COVID-19 response, identifying best practices and...
Niger: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Niger: Analyse de...
Mozambique: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Mozambique: Analysis of country COVID-19 response, identifying best...
Botswana: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Botswana: Analysis of country COVID-19 response, identifying best...
Syria: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Syria: Analysis of country COVID-19 response, identifying best practices...
Bolivia: Análisis de la respuesta de los países a la COVID-19, identificando las mejores prácticas y las brechas cruciales a tener en cuenta en los planes de respuesta futuros,Bolivia: Análisis...
This good practice statement has been developed based on the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 11 August 2022.
These are the annexes to the Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19.
This background document was prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines to inform the discussions of SAGE for Valneva vaccine...
This interim recommendation pertains to the COVID-19 Valneva vaccine (VLA2001), developed by Valneva’s research and development teams in France and Austria with the marketing authorization holder,...
This document explains why gender considerations matter for immunization programming with examples of common gender-related barriers, along with concrete gender-responsive approaches and actions that...
This guide breaks down the development of situation analysis into four well detailed sections.
1. Collection and gathering of data
2. Complete immunization coverage and equity...
This guide is designed to help anyone in the health and immunization system identify and address barriers or leverage drivers to immunization by locally codesigning and evaluating human-centred,...
This position paper discusses the development of the BeSD for vaccine tool. It covers the 4 phases and key activities for the development of the tool. They include:
• Initial development of the...